Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed cases

被引：17

作者：

Gentile, Massimo ^{[1
]}

Shanafelt, Tait D. ^{[2
,3
]}

Mauro, Francesca R. ^{[4
]}

Laurenti, Luca ^{[5
]}

Rossi, Davide ^{[6
,7
]}

Molica, Stefano ^{[8
]}

Vincelli, Iolanda ^{[9
]}

Cutrona, Giovanna ^{[10
]}

Uccello, Giuseppina ^{[1
]}

Pepe, Sara ^{[4
]}

Vigna, Ernesto ^{[1
]}

Tripepi, Giovanni ^{[11
]}

Chaffee, Kari G. ^{[12
]}

Parikh, Sameer A. ^{[2
]}

Bossio, Sabrina ^{[13
]}

Recchia, Anna Grazia ^{[13
]}

Innocenti, Idanna ^{[5
]}

Pasquale, Raffaella ^{[5
]}

Neri, Antonino ^{[14
,15
]}

Ferrarini, Manlio ^{[16
]}

Gaidano, Gianluca ^{[17
,18
]}

Foa, Robin ^{[4
]}

Morabito, Fortunato ^{[13
]}

机构：

[1] AO Cosenza, Hematol Unit, Dept Oncohematol, Cosenza, Italy

[2] Mayo Clin, Dept Internal Med, Rochester, MN USA

[3] Mayo Clin, Div Hematol, Rochester, MN USA

[4] Sapienza Univ, Dept Cellular Biotechnol & Hematol, Rome, Italy

[5] Catholic Univ Hosp, Dept Hematol, Rome, Italy

[6] Oncol Inst Southern Switzerland, Dept Oncol & Hematol, Bellinzona, Switzerland

[7] Inst Oncol Res, Bellinzona, Switzerland

[8] Pugliese Ciaccio Hosp, Dept Oncol & Haematol, Catanzaro, Italy

[9] Hematol Unit Reggio, Dept Oncol & Hematol, Calabria, Italy

[10] IRCCS, Osped Policlin, UO Mol Pathol, Dept Oncol & Hematol, Genoa, Italy

[11] CNR, Ist Biomed & Immunol Mol, Reggio Di Calabria, Italy

[12] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA

[13] Azienda Sanit Prov Cosenza, Dept Oncol & Hematol, Biotechnol Res Unit, Aprigliano, CS, Italy

[14] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy

[15] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Hematol CTMO, Milan, Italy

[16] Osped Policlin, Dept Oncol & Hematol, Direz Sci, IRCCS, Genoa, Italy

[17] Univ Piemonte Orientale, Div Haematol, Novara, Italy

[18] Univ Piemonte Orientale, Dept Translat Med, Novara, Italy

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2018年 / 93卷 / 02期

关键词：

CHRONIC LYMPHOCYTIC-LEUKEMIA; VALIDATION; INDEX;

D O I：

10.1002/ajh.24960

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E35 / E37

页数：3

共 6 条

[1]

CLL IPI working group, 2016, LANCET ONCOL, V17, P779

[2] Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI [J].

Delgado, Julio ;

Doubek, Michael ;

Baumann, Tycho ;

Kotaskova, Jana ;

Molica, Stefano ;

Mozas, Pablo ;

Rivas-Delgado, Alfredo ;

Morabito, Fortunato ;

Pospisilova, Sarka ;

Montserrat, Emili .

AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (04) :375-380

[3] Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients [J].

Gentile, Massimo ;

Shanafelt, Tait D. ;

Rossi, Davide ;

Laurenti, Luca ;

Mauro, Francesca R. ;

Molica, Stefano ;

Cutrona, Giovanna ;

Uccello, Giuseppina ;

Campanelli, Melissa ;

Vigna, Ernesto ;

Tripepi, Giovanni ;

Chaffee, Kari G. ;

Parikh, Sameer A. ;

Bossio, Sabrina ;

Recchia, Anna Grazia ;

Innocenti, Idanna ;

Pasquale, Raffaella ;

Neri, Antonino ;

Ferrarini, Manlio ;

Gaidano, Gianluca ;

Foa, Robin ;

Morabito, Fortunato .

BLOOD, 2016, 128 (16) :2093-2095

[4] Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial [J].

Hallek, M. ;

Fischer, K. ;

Fingerle-Rowson, G. ;

Fink, A. M. ;

Busch, R. ;

Mayer, J. ;

Hensel, M. ;

Hopfinger, G. ;

Hess, G. ;

von Gruenhagen, U. ;

Bergmann, M. ;

Catalano, J. ;

Zinzani, P. L. ;

Caligaris-Cappio, F. ;

Seymour, J. F. ;

Berrebi, A. ;

Jaeger, U. ;

Cazin, B. ;

Trneny, M. ;

Westermann, A. ;

Wendtner, C. M. ;

Eichhorst, B. F. ;

Staib, P. ;

Buehler, A. ;

Winkler, D. ;

Zenz, T. ;

Boettcher, S. ;

Ritgen, M. ;

Mendila, M. ;

Kneba, M. ;

Doehner, H. ;

Stilgenbauer, S. .

LANCET, 2010, 376 (9747) :1164-1174

[5]

Kipps TJ, 2017, NAT REV DIS PRIMERS, V3, P17008

[6] The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients [J].

Molica, Stefano ;

Shanafelt, Tait D. ;

Giannarelli, Diana ;

Gentile, Massimo ;

Mirabelli, Rosanna ;

Cutrona, Giovanna ;

Levato, Luciano ;

Di Renzo, Nicola ;

Di Raimondo, Francesco ;

Musolino, Caterina ;

Angrilli, Francesco ;

Fama, Angelo ;

Recchia, Anna Grazia ;

Chaffee, Kari G. ;

Neri, Antonino ;

Kay, Neil E. ;

Ferrarini, Manlio ;

Morabito, Fortunato .

AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (11) :1090-1095

← 1 →